Old Web
English
Sign In
Acemap
>
Paper
>
Treatment of refractory anti-NXP2 and anti-TIF1γ dermatomyositis with tofacitinib.
Treatment of refractory anti-NXP2 and anti-TIF1γ dermatomyositis with tofacitinib.
2020
Irene Navarro-Navarro
David Jiménez Gallo
María Eugenia Rodríguez Mateos
Carmen Rodríguez Hernández
Mario Linares Barrios
Keywords:
Dermatology
Dermatomyositis
Refractory
Tofacitinib
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]